What we did
Capitalmind Investec supported the CNIM Group throughout the entire sale process: preparation of marketing documentation, research and selection of strategic buyers and management of carve-out issues.
About the deal
Oncodesign, completed the acquisition of the pre-clinical and clinical study activities of Bertin Pharma.
Oncodesign was founded more than 20 years ago by Dr. Philippe Genne, and is a biopharmaceutical company that specializes in ‘precision medicine’, combining medicinal chemistry, pharmacology, regulatory bioanalysis and advanced medical imaging. Oncodesign has 215 employees and subsidiaries in Canada and the United States.
By disposing of its pharma & biotech activities, the CNIM Group intends to focus on its core business, primarily in the fields of Energy, Environment, Defence and Security. Bertin Pharma currently employs 125 people and generates a turnover of 16 million euros.